Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Qvar RediHaler (beclomethasone) and Symbicort (budesonide/formoterol) are both inhalers used to manage asthma, but they have some key differences. Qvar RediHaler is an inhaled corticosteroid (ICS) that works by reducing inflammation in the lungs, and it is used for long-term asthma control. It is not available in a generic form and should not be used with a spacer. Symbicort, on the other hand, is a combination inhaler that includes both budesonide, a corticosteroid, and formoterol, a long-acting beta-agonist (LABA). This combination helps reduce inflammation and relaxes the muscles around the airways, making it effective for both asthma and chronic obstructive pulmonary disease (COPD). Symbicort is available in generic versions and can provide some relief within 15 minutes, although it is not a rescue inhaler. Both medications require regular use and can cause oral thrush if you don't rinse your mouth after use. Symbicort can also cause additional risks like potential bone loss and higher blood sugar levels with long-term use.
Qvar redihaler (beclomethasone)
Symbicort (budesonide / formoterol)
Qvar redihaler (beclomethasone)
Symbicort (budesonide / formoterol)
Summary of Qvar RediHaler vs. Symbicort
Summary for Inhaled corticosteroid (ICS)
Prescription only
QVAR RediHaler, the brand name for beclomethasone dipropionate HFA inhaler, is an inhaled corticosteroid. It's used in people ages 4 years and older for the maintenance treatment of asthma. This medication is inhaled through the mouth twice per day. Like other inhaled steroid medications, Qvar RediHaler (beclomethasone) can cause upper respiratory tract infections and oral thrush as side effects.
Summary for IC / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler containing a steroid (budesonide) and a long-acting beta-agonist (formoterol). Both medications work together to treat asthma and chronic obstructive pulmonary disease (COPD). The typical dose for Symbicort (budesonide / formoterol) is 2 inhalations by mouth twice a day, about 12 hours apart. Common side effects include symptoms of common cold, such as stuffy nose and cough. It's available in two different strengths, both with generic versions.
Indications of Qvar RediHaler vs. Symbicort
Indications for
•Maintenance treatment of asthma in people ages 4 years and older